Tests a brain implant that lets paralyzed people control a computer with thought
Tests a brain sensor placed in the motor cortex in adults with tetraplegia.
Plain-language title generated from the registry record
Registry title: BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
Key facts
- Where
- Atlanta, Boston, Houston, Providence, Sacramento, and Stanford, United StatesSee the 6 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT00912041, who can take part
Where in United States
- Emory University School of MedicineAtlanta, United StatesTaking people
- Massachusetts General HospitalBoston, United StatesTaking people
- Baylor College of MedicineHouston, United StatesTaking people
- Providence VA Medical CenterProvidence, United StatesTaking people
- University of California - DavisSacramento, United StatesTaking people
- Stanford University School of MedicineStanford, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Leigh R. Hochberg, MD, PhD.
- Trial code
- NCT00912041
- Record updated
- 1 June 2026
- Original description
The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.Read full original descriptionShow less
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.
Inclusion: Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders; Complete or incomplete tetraplegia (quadriplegia); Must live within a three-hour drive of the Study site; (There are additional inclusion criteria).
Exclusion: Chronic oral or intravenous steroids or immunosuppressive therapy; Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses; Other serious disease or disorder that could seriously affect ability to participate in the study; (There are additional exclusion criteria).